title: Association between GSTM1*0 and squamous dysplasia of the esophagus in the high risk region of Linxian, China.
abstract: Individuals with specific phase I and phase II enzyme polymorphisms may be at increased risk for squamous cell carcinoma of the esophagus. However, to our knowledge there has been only one previous report that evaluates a potential role for these polymorphisms in increasing risk for preneoplastic squamous lesions of the esophagus. To explore this further, we examined polymorphisms in CYP1A1, CYP2E1, GSTM1 and GSTT1, both independently and in combination, for potential associations with the risk of biopsy-proven squamous dysplasia of the esophagus in asymptomatic adults from Linxian, a high risk region in China. Cases consisted of 56 individuals from an esophageal cancer screening study with an endoscopic biopsy diagnosis of mild or moderate squamous dysplasia. Each case was matched on age (+/- 1 year) and gender to a control. Controls were defined as screening study participants with an endoscopic biopsy diagnosis of normal mucosa or esophagitis. DNA was extracted from frozen cell samples obtained by cytologic balloon examination and genotyped using standard methods. Individuals who were GSTM1 null (homozygous for GSTM1*0) were found to have a tendency for an increased risk of esophageal squamous dysplasia (odds ratio=2.6, 95% CI, 0.9-7.4). No excess risks were observed for inheritance of other putative at risk genotypes CYP1A1*2B, CYP2E1*6 or GSTT1*0. The risk associated with the inheritance of combined genotypes was not significantly different than the risk estimates from the univariate analysis. These results are consistent with the notion that exposure to environmental carcinogens that are detoxified by GSTM1, such as polycyclic aromatic hydrocarbons, may contribute to the etiology of esophageal cancer in Linxian.
authors.affiliation: The Cancer Prevention Studies Branch, Division of Clinical Sciences, National Cancer Institute NIH, Bethesda, MD 20892, USA. mr166i@nih.gov
authors.forename: M J
authors.initials: MJ
authors.lastname: Roth
authors.forename: S M
authors.initials: SM
authors.lastname: Dawsey
authors.forename: G
authors.initials: G
authors.lastname: Wang
authors.forename: J A
authors.initials: JA
authors.lastname: Tangrea
authors.forename: B
authors.initials: B
authors.lastname: Zhou
authors.forename: D
authors.initials: D
authors.lastname: Ratnasinghe
authors.forename: K G
authors.initials: KG
authors.lastname: Woodson
authors.forename: O A
authors.initials: OA
authors.lastname: Olivero
authors.forename: M C
authors.initials: MC
authors.lastname: Poirier
authors.forename: B L
authors.initials: BL
authors.lastname: Frye
authors.forename: P R
authors.initials: PR
authors.lastname: Taylor
authors.forename: A
authors.initials: A
authors.lastname: Weston
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000201:enzymology / Q000209:etiology* / Q000235:genetics; D004938:Esophageal Neoplasms / Q000201:enzymology / Q000209:etiology* / Q000235:genetics; D005838:Genotype; D005982:Glutathione Transferase / Q000235:genetics*; D006801:Humans; D007527:Isoenzymes / Q000235:genetics*; D011230:Precancerous Conditions / Q000201:enzymology / Q000209:etiology* / Q000235:genetics; D012306:Risk
chemical_list: D007527:Isoenzymes; D005982:Glutathione Transferase